Physician profile
Todd P Stitik
NPI 1356361349
$370,058.03
in general payments reported to CMS, 2019-2025
17 companies · $58K in 2025
The $58K reported for 2025 was more than what 99% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $14K · 2021: $43K · 2022: $56K · 2023: $89K · 2024: $89K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $118K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $43K · Travel and Lodging: $28K · Food and Beverage: $2,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $118,180.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,820.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $43,000.00 |
| Travel and Lodging | $28,200.19 |
| Food and Beverage | $2,010.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $143,095.32 | 2022-2025 | Xeomin |
| Konica Minolta Healthcare Americas, INC | $102,044.77 | 2019-2024 | |
| Ge Healthcare | $72,369.63 | 2020-2025 | |
| Abbvie INC. | $16,800.00 | 2023-2025 | Botox |
| Ibsa Pharma INC. | $15,234.46 | 2020-2024 | Licart |
| Fidia Pharma USA INC. | $8,098.75 | 2019 | |
| Orthogenrx INC. | $7,145.78 | 2019-2021 | |
| Ibsa Institut Biochimique Sa | $2,989.46 | 2021 | |
| Stratus Medical, LLC | $926.55 | 2023-2024 | Nimbus |
| Fujifilm Sonosite, INC. | $600.00 | 2023 | Sonosite St |
| Spr Therapeutics, INC | $416.16 | 2021-2024 | Sprint Pns System |
| Lilly USA, LLC | $118.59 | 2020 | |
| Bioventus LLC | $96.84 | 2021 | |
| Pacira Therapeutics, INC. | $50.00 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $35.72 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22.00 | 2019 | |
| Biogen, INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Stitik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.